Name: China Pharmaceutical Market Size, Share, Growth and Industry Report
Creator: IMARC Group
License: https://www.imarcgroup.com/privacy-policy
Keywords: China Pharmaceutical Market Report

China Pharmaceutical Market Report by Type (Pharmaceutical Drugs, Biologics), Nature (Organic, Conventional), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A23447

Buy Now New Year Sale

China Pharmaceutical Market Overview:

The China pharmaceutical market is projected to exhibit a growth rate (CAGR) of 7.50% during 2024-2032. The market is driven by numerous factors, which include the rising geriatric population, increasing number of healthcare facilities like hospitals and clinics, prevalence of chronic diseases such as diabetes, arthritis, and cardiovascular issues.

Report Attribute	Key Statistics
Base Year	2023
Forecast Years	2024-2032
Historical Years	2018-2023
Market Growth Rate (2024-2032)	7.50%

China Pharmaceutical Market Trends:

Rising Geriatric Population

The growing demand for pharmaceutical products among the geriatric population, as they are more prone to chronic diseases, is influencing the market positively. Elderly individuals are more vulnerable to conditions like diabetes, heart problems, and cancer as they get older. This demographic trend in China creates a substantial and growing market for pharmaceutical products tailored for managing and treating these chronic conditions. In addition, the market is expanding as a result of increasing awareness among individuals about the importance of early diagnosis, treatment, and management of chronic illnesses. Furthermore, pharmaceutical companies are putting more and more effort into creating drugs that are specially designed to meet the needs of elderly individuals. These medications include formulations that are designed to be easier to administer, have reduced side effects, and are more effective in managing age-related conditions. Companies are also focusing on producing more cost-effective pharmaceutical products to make them accessible to a larger elderly population in China. The population of people over 60 years old in the country is projected to reach 28% by 2040, due to longer life expectancy and declining fertility rates, as stated by the World Health Organization (WHO).

Increasing Number of Healthcare Facilities

As per CEIC, the number of hospitals in China were reported 39,000.000 unit in 2023 year, an increase as compared to 2022. The rising utilization of pharmaceutical products in hospitals, clinics, surgical centers, and nursing homes is bolstering the market growth. These facilities have huge patient influxes that are suffering from a wide range of disorders. Healthcare providers are prescribing various drugs that are beneficial in their healing process. Furthermore, governing authorities in China are concentrating on enhancing healthcare facilities by financing the purchase of advanced machinery and medical equipment. They are also focusing on providing numerous tax breaks, financial incentives, and support for biotech startups and innovation hubs, in addition to granting various product approvals.

China Pharmaceutical Market News:

20 March 2024: Sinopharm signed a strategic cooperation agreement with Fresenius Kabi (China) Co Ltd. This aims to further consolidate and expand cooperation in areas like pharmaceutical sales, warehousing, distribution, healthcare, and medical care and wellness, with the goal of bringing better products and services to the Chinese people.
30 October 2023: Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui) collaborated with Merck, a leading science and technology company. The partnership includes an exclusive license worldwide to develop, manufacture, and commercialize Hengrui’s next-generation potent and selective PARP1 (poly (ADP-ribose) polymerase 1) trapping inhibitor HRS-1167. The agreement also includes an option for an exclusive license worldwide to develop, manufacture, and commercialize Hengrui’s Claudin-18.2 antibody-drug conjugate (ADC) SHR-A1904.

China Pharmaceutical Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type and nature.

Type Insights:

Pharmaceutical Drugs
- Cardiovascular Drugs
- Dermatology Drugs
- Gastrointestinal Drugs
- Genito-Urinary Drugs
- Hematology Drugs
- Anti-Infective Drugs
- Metabolic Disorder Drugs
- Musculoskeletal Disorder Drugs
- Central Nervous System Drugs
- Oncology Drugs
- Ophthalmology Drugs
- Respiratory Diseases Drugs
Biologics
- Monoclonal Antibodies (MAbS)
- Therapeutic Proteins
- Vaccines

The report has provided a detailed breakup and analysis of the market based on the type. This includes pharmaceutical drugs (cardiovascular drugs , dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorder drugs, musculoskeletal disorder drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs) and biologics (monoclonal antibodies (MAbS), therapeutic proteins, and vaccines).

Nature Insights:

Organic
Conventional

A detailed breakup and analysis of the market based on the nature have also been provided in the report. This includes organic and conventional.

Region Insights:

North China
East China
South Central China
Southwest China
Northwest China
Northeast China

The report has also provided a comprehensive analysis of all the major regional markets, which include North China, East China, South Central China, Southwest China, Northwest China, and Northeast China.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

China Pharmaceutical Market Report Coverage:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Type Nature Region
Types Covered	Pharmaceutical Drugs: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs Biologics: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
Natures Covered	Organic, Conventional
Regions Covered	North China, East China, South Central China, Southwest China, Northwest China, Northeast China
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the China pharmaceutical market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the China pharmaceutical market?
What is the breakup of the China pharmaceutical market on the basis of type?
What is the breakup of the China pharmaceutical market on the basis of nature?
What are the various stages in the value chain of the China pharmaceutical market?
What are the key driving factors and challenges in the China pharmaceutical?
What is the structure of the China pharmaceutical market and who are the key players?
What is the degree of competition in the China pharmaceutical market?

Key Benefits for Stakeholders:

IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the China pharmaceutical market from 2018-2032.
The research report provides the latest information on the market drivers, challenges, and opportunities in the China pharmaceutical market.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the China pharmaceutical industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.